NCT06789367View on ClinicalTrials.gov

The Effect of Dexamethasone Administration Route in PENG Block for Pediatric Hip Surgery

PHASE4RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

February 1, 2025

Primary Completion Date

February 28, 2026

Study Completion Date

March 31, 2026

Conditions
Hip DysplasiaHip Disease
Interventions
DRUG

perineural Dexamethasone 4mg

PENG block with 20ml 0.2% ropivacaine + 4mg perineural Dexamethasone

DRUG

intravenous Dexamethsone 4mg

PENG block with 20ml 0.2% ropivacaine + 4mg intravenous Dexamethasone

Trial Locations (1)

60-701

RECRUITING

Poznan University of Medical Sciences, Poznan

All Listed Sponsors
lead

Poznan University of Medical Sciences

OTHER

NCT06789367 - The Effect of Dexamethasone Administration Route in PENG Block for Pediatric Hip Surgery | Biotech Hunter | Biotech Hunter